MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study
Psychedelic Alpha’s Josh Hardman speaks with Aaron Wolfgang, Chief of Inpatient Psychiatry at the US Army, about an unprecedented study that will see around ninety active-duty service members receive MDMA-assisted therapy for PTSD. They discuss the trial’s unique design, which includes a D-amphetamine active placebo and simultaneous dosing, as well as timelines, funding, and the specific challenges this population brings with it.